This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a 2,2-dimethyloxazolidine ring system, which provides structural rigidity during peptide assembly.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 878797-01-4
Fmoc-Tyr(tBu)-Ser(Psi(Me,Me)pro)-OH
Research reagent for peptide synthesis
Fmoc-Leucine-Serine Pseudoproline
solid phase peptide synthesis building block
(4S)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
research compound
4-Oxazolidinecarboxylic acid, 3-[(2S)-3-(1,1-dimethylethoxy)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-oxopropyl]-2,2-dimethyl-, (4S)-
Pharmaceutical intermediate for peptide synthesis
4-CHLORO-2,5-DIFLUOROBENZALDEHYDE
pharmaceutical intermediate
(R)-tert-Butyl (piperidin-3-ylmethyl)carbamate
Pharmaceutical intermediate for drug synthesis
(R)-3-N-Cbz-Aminopyrrolidine
Pharmaceutical intermediate
1-(propan-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
boronic ester synthetic intermediate
(4S)-3-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-phenylpropanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
PQJUKTSKOYOXMZ-UIOOFZCWSA-N
CC1(N([C@@H](CO1)C(=O)O)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)C